SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12643457
Source:
http://linkedlifedata.com/resource/pubmed/id/12643457
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007202
,
umls-concept:C0087111
,
umls-concept:C1705480
,
umls-concept:C1963944
pubmed:issue
6
pubmed:dateCreated
2003-3-19
pubmed:abstractText
Hypotension refractory to maximal doses of alpha-adrenergic drugs after cardiac operations employing cardiopulmonary bypass (CPB) has been referred as "vasoplegic syndrome." Vasopressin has been used for its therapy with encouraging results.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8908809
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Vasopressins
pubmed:status
MEDLINE
pubmed:issn
0886-0440
pubmed:author
pubmed-author:KouchoukosNicholas TNT
,
pubmed-author:MasettiPaoloP
,
pubmed-author:MurphySuzan FSF
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
485-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12643457-Adrenergic alpha-Agonists
,
pubmed-meshheading:12643457-Adrenergic alpha-Antagonists
,
pubmed-meshheading:12643457-Aged
,
pubmed-meshheading:12643457-Aged, 80 and over
,
pubmed-meshheading:12643457-Blood Pressure
,
pubmed-meshheading:12643457-Cardiac Output
,
pubmed-meshheading:12643457-Cardiopulmonary Bypass
,
pubmed-meshheading:12643457-Female
,
pubmed-meshheading:12643457-Hospital Mortality
,
pubmed-meshheading:12643457-Humans
,
pubmed-meshheading:12643457-Hypotension
,
pubmed-meshheading:12643457-Infusions, Intravenous
,
pubmed-meshheading:12643457-Male
,
pubmed-meshheading:12643457-Middle Aged
,
pubmed-meshheading:12643457-Paralysis
,
pubmed-meshheading:12643457-Postoperative Complications
,
pubmed-meshheading:12643457-Reoperation
,
pubmed-meshheading:12643457-Syndrome
,
pubmed-meshheading:12643457-Systole
,
pubmed-meshheading:12643457-Treatment Outcome
,
pubmed-meshheading:12643457-Vascular Resistance
,
pubmed-meshheading:12643457-Vasoconstrictor Agents
,
pubmed-meshheading:12643457-Vasopressins
pubmed:articleTitle
Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass.
pubmed:affiliation
Division of Cardiovascular and Thoracic Surgery and the Heart Center, Missouri Baptist Medical Center, St. Louis, Missouri, USA.
pubmed:publicationType
Journal Article